CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...

GLP-1 therapies primarily use single-use injectable pens, contributing to medical waste challenges. The pharmaceutical ...

The 85th American Diabetes Association Scientific Sessions have shown the depth of China’s play for the GLP-1 market, with ...

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...

Ecnoglutide is a GLP-1 receptor agonist, part of a growing class of drugs that help control blood sugar and reduce hunger.

A GP shares her journey using using GLP-1 medication as primary care prescribing of tirzepatide for obesity begins this week.

Adults with overweight or obesity who received once-weekly ecnoglutide, a novel GLP-1 receptor agonist, had superior and ...

The strict rules to qualify for a Mounjaro prescription from GPs in the UK have been revealed as the 'weight loss' drug is ...

A new oral anti-diabetes pill, orforglipron, shows similar effectiveness to injectable GLP-1 drugs in a Phase 3 trial.

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...

The government issued a serious warning relating to sexual health for Mounjaro users. And tomorrow (23 June), the weight loss ...

What is Mounjaro and how does the weight-loss jab work? Popular drug now available on NHS - From June 23, the weight loss jab ...